Memorializes Governor Kathy Hochul to proclaim May 2026 as Neurofibromatosis Month in New York.

This resolution memorializes Governor Kathy Hochul to proclaim May 2026 as Neurofibromatosis Month in the State of New York. Neurofibromatosis (NF) is a debilitating tumor disorder affecting over 130,000 Americans. The resolution highlights the importance of increasing awareness and research efforts for NF, noting the work of organizations like Neurofibromatosis Northeast and the NF Research Program. It also mentions the FDA approval of Koselugo for NF1 treatment and the potential of new clinical trials.

Memorializes Governor Kathy Hochul to proclaim May 2026 as Neurofibromatosis Month in New York.

This resolution memorializes Governor Kathy Hochul to proclaim May 2026 as Neurofibromatosis Month in the State of New York. Neurofibromatosis (NF) is a debilitating tumor disorder affecting over 130,000 Americans. The resolution highlights the importance of increasing awareness and research efforts for NF, noting the work of organizations like Neurofibromatosis Northeast and the NF Research Program. It also mentions the FDA approval of Koselugo for NF1 treatment and the potential of new clinical trials.